Critical appraisal of animal models of multiple sclerosis

被引:66
作者
Baker, David [1 ]
Gerritsen, Wouter [2 ]
Rundle, Jon [3 ]
Amor, Sandra [2 ]
机构
[1] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, Neurosci & Trauma Ctr, London E1 2AT, England
[2] Free Univ VU Med Ctr, Dept Pathol, Amsterdam, Netherlands
[3] Imperial Coll London, Hammersmith Hosp Campus, Wolfson Neurosci Labs, London, England
基金
英国国家替代、减少和改良动物研究中心;
关键词
animal models; EAE; multiple sclerosis; therapies; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; AXONAL DEGENERATION; MEDIATED NEUROPROTECTION; MOUSE MODELS; INDUCTION; PROTEIN; PATHOGENESIS; PHENYTOIN;
D O I
10.1177/1352458511398885
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Experimental autoimmune encephalomyelitis (EAE) is a spectrum of neurological disorders in laboratory animals that is used to model multiple sclerosis (MS). However, few agents have translated from efficacy in EAE to the treatment of human disease. Although this may reflect species differences in pathological disease mechanisms, importantly it may also relate to the practice of how drugs and models are currently used. This often bears very little resemblance to the clinical scenarios where treatments are investigated, such that lack of appreciation of the biology of disease may doom drugs to failure. The use of EAE is critically appraised with the aim of provoking thought, improving laboratory practise and aiding researchers and reviewers to address quality issues when undertaking, reporting and interpreting animal studies related to MS research. This is important as many researchers using EAE could and should do more to improve the quality of the studies.
引用
收藏
页码:647 / 657
页数:11
相关论文
共 71 条
[21]   Multiple sclerosis [J].
Compston, Alastair ;
Coles, Alasdair .
LANCET, 2008, 372 (9648) :1502-1517
[22]   Mouse models for multiple sclerosis: Historical facts and future implications [J].
Croxford, Andrew L. ;
Kurschus, Florian C. ;
Waisman, Ari .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (02) :177-183
[23]   Cannabinoid-mediated neuroprotection, not immuno suppression, may be more relevant to multiple sclerosis [J].
Croxford, J. Ludovic ;
Pryce, Gareth ;
Jackson, Samuel J. ;
Ledent, Catherine ;
Giovannoni, Gavin ;
Pertwee, Roger G. ;
Yamamura, Takashi ;
Baker, David .
JOURNAL OF NEUROIMMUNOLOGY, 2008, 193 (1-2) :120-129
[24]   Different therapeutic outcomes in experimental allergic encephalomyelitis dependant upon the mode of delivery of IL-10: A comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system [J].
Croxford, JL ;
Feldmann, M ;
Chernajovsky, Y ;
Baker, D .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :4124-4130
[25]   Potential role of humoral immunity in the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) [J].
del Pilar Martin, Maria ;
Monson, Nancy L. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :2735-2749
[26]  
Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004
[27]   Pathogenesis of axonal and neuronal damage in multiple sclerosis [J].
Dutta, Ranjan ;
Trapp, Bruce D. .
NEUROLOGY, 2007, 68 :S22-S31
[28]   High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model [J].
Ellmerich, S ;
Mycko, M ;
Takacs, K ;
Waldner, H ;
Wahid, FN ;
Boyton, RJ ;
King, RHM ;
Smith, PA ;
Amor, S ;
Herlihy, AH ;
Hewitt, RE ;
Jutton, M ;
Price, DA ;
Hafler, DA ;
Kuchroo, VK ;
Altmann, DM .
JOURNAL OF IMMUNOLOGY, 2005, 174 (04) :1938-1946
[29]   Virus demyelination [J].
Fazakerley, JK ;
Walker, R .
JOURNAL OF NEUROVIROLOGY, 2003, 9 (02) :148-164
[30]  
Fazekas G, 2000, Rev Immunogenet, V2, P115